Ocular Therapeutix Inc (NASDAQ:OCUL) announced interim 7-month data from its U.S. Phase 1 trial evaluating OTX-TKI for wet age-related macular degeneration…
Aquestive Therapeutics Inc (NASDAQ:AQST) announced positive topline results from the EPIPHAST 2 trial for its AQST-109 epinephrine sublingual film. The trial…
Japan’s health agency has approved AstraZeneca Plc’s (NASDAQ:AZN) Koselugo (selumetinib) for pediatric patients with plexiform neurofibromas (PNs) in neurofibromatosis type 1…
First spine navigation software to receive clearance from the FDA for use with pediatric patients aged 13 and older
Stryker (NYSE:SYK), one of the world's leading medical technology companies, announced today the
100% of study participants (n=25) achieved robust responses to oral mavorixafor
100% of neutropenic participants (n=14) achieved normalized neutrophil counts
Robust responses achieved across all CN disorders
The FDA authorized an additional five batches of Moderna Inc’s (NASDAQ:MRNA) updated Covid booster shots made at Catalent Inc‘s (NYSE:CTLT) Indiana facility after…
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, received four new approvals from Japan's Ministry of Health, Labor and Welfare